均瑶健康首季净利降 2020上市募资9.4亿去年转亏

Core Viewpoint - Junyao Health reported a significant decline in both revenue and net profit for the fiscal year 2024, indicating potential challenges in its operational performance [1][3]. Financial Performance Summary - For the year 2024, the company achieved operating revenue of 1.458 billion yuan, a decrease of 10.77% compared to the previous year [1][3]. - The net profit attributable to shareholders was -29.12 million yuan, down 150.57% from 57.58 million yuan in the previous year [1][3]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was -57.99 million yuan, a decline of 287.62% from 30.91 million yuan in the previous year [1][3]. - The net cash flow from operating activities was 32.65 million yuan, a decrease of 61.95% year-on-year [1][3]. Q1 2025 Performance Summary - In the first quarter of 2025, the company reported operating revenue of 401.48 million yuan, an increase of 1.41% year-on-year [4][6]. - The net profit attributable to shareholders was 10.91 million yuan, a decrease of 58.29% compared to the same period last year [4][6]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was 7.03 million yuan, down 70.46% year-on-year [4][6]. - The net cash flow from operating activities was -97.06 million yuan, compared to -129.49 million yuan in the same period last year [4][6]. Dividend Distribution Plan - The company plans to distribute a cash dividend of 0.08 yuan per share (tax included) to all shareholders, totaling approximately 46.87 million yuan [1][3].